Products for Research Use Only
RegisterLogin

Lenzilumab

CAT: 0804-HY-P99207-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99207-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Lenzilumab (KB 003) is a human monoclonal antibody targeting CSF2/GM-CSF for COVID-19, chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML) studies[1][2].
CAS Number
1229575-09-0
Product Name Alternative
KB 003
UNSPSC
12352203
Target
SARS-CoV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/lenzilumab.html
Purity
99.64
Solubility
10 mM in DMSO
Smiles
[Lenzilumab]
Molecular Weight
(145.72 kDa)
References & Citations
[1]Rosalie M Sterner, et al. GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts. Blood. 2019 Feb 14;133 (7) :697-709.|[2]Zelalem Temesgen, et al. GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study. Mayo Clin Proc. 2020 Nov;95 (11) :2382-2394.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
E40YR1346Lenzilumab
GTR18338036-01Lenzilumab Antibody
591958Lenzilumab (CSF2)
MBS1563368-01Research Grade Lenzilumab
E100500Lenzilumab ELISA Kit
KBI1421KRIBIOLISA™ Lenzilumab ELISA
E55B0288Lenzilumab (Reference antibody)
ICH5166-20mgLenzilumab Biosimilar - Research Grade
ABS-139-100ugLenzilumab Biosimilar, Research Grade
GTR18780638-01(Lenzilumab) Biosimilar Reference Antibody

Popular Products